ADIPOQ and polycystic ovary syndrome: Previously, we have shown that levels of molecules associated with adiponectin signaling are decreased in endometria from women with obesity-associated IR and PCOS [9] compared with the group of women with obesity only, suggesting a potential lower insulin-sensitizing action of adiponectin in this tissue.